Home NDC 70518-3907 terbinafine hydrochloride
Product NDC 70518-3907
11-digit product format 705183907
Labeler code 70518
Product ID 70518-3907_4d26c515-0886-5b32-e063-6294a90a9ebb
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name terbinafine hydrochloride
Dosage form TABLET
Route ORAL
Labeler REMEDYREPACK INC.
Application ANDA078163
Marketing category ANDA
Marketing start 2023-11-03
Substance TERBINAFINE HYDROCHLORIDE
Active strength 250 mg/1
Pharmacologic classes Allylamine Antifungal [EPC], Allylamine [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 4 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A078163-001 TERBINAFINE HYDROCHLORIDE TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A078163-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A078163-001 TERBINAFINE HYDROCHLORIDE EQ 250MG BASE TABLET / ORAL AB 2007-07-02 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Additional Listing Data#
Finished product Yes
Brand name base terbinafine hydrochloride
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TERBINAFINE HYDROCHLORIDE 250 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 012C11ZU6G Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 313222 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70518-3907-0 terbinafine hydrochloride 90 in 1 BOTTLE, PLASTIC TABLET 90 6 70518-3907-1 terbinafine hydrochloride 30 in 1 BOTTLE, PLASTIC TABLET 30 6 70518-3907-2 terbinafine hydrochloride 45 in 1 BOTTLE, PLASTIC TABLET 45 6 70518-3907-3 terbinafine hydrochloride 30 in 1 BLISTER PACK TABLET 30 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70518-3907 TERBINAFINE HYDROCHLORIDE TABLET [REMEDYREPACK INC.] 4 Current NDC, 4 package rows 20240510_2886b2ff-815f-4621-bc28-1fea082c1920.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 5 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 70518-3907-0 70518390700 90 in 1 BOTTLE, PLASTIC Historical 70518-3907-1 70518390701 30 TABLET in 1 BOTTLE, PLASTIC (70518-3907-1) 30 tablet 2023-11-05 0 Current 70518-3907-2 70518390702 45 in 1 BOTTLE, PLASTIC Historical 70518-3907-3 70518390703 30 TABLET in 1 BLISTER PACK (70518-3907-3) 30 tablet 2026-03-16 No No Current